Insife
Revolutionizing Pharmacovigilance with Cutting-Edge Technology
Insife is a leading provider of pharmacovigilance solutions, offering a comprehensive platform and expert consulting to help pharmaceutical and biotech companies efficiently navigate drug safety processes. With nearly 100 safety experts worldwide, Insife provides the largest Europe-based pharmacovigilance services and solutions in the industry. The company's flagship product HALOPV is an end-to-end system to manage multivigilance processes from operational to scientific tasks. Insife also offers regulatory intelligence, hosting services, and strategic consulting to deliver outstanding domain expertise across the US, Europe, and Asia. With a commitment to transforming drug safety through innovation, Insife is changing the technology landscape for pharmacovigilance worldwide.
In March 2024, it was announced that Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, had acquired Insife. The acquisition will enable Qinecsa to leverage Insife's expertise in software development and consultancy, to enhance its existing pharmacovigilance services and accelerate further innovation in the field. Together, the companies will continue to lead the industry in advancing patient safety, drug development, and regulatory compliance through AI-driven technologies and cutting-edge solutions.
Revolutionizing Pharmacovigilance with Cutting-Edge Technology
Insife is a leading provider of pharmacovigilance solutions, offering a comprehensive platform and expert consulting to help pharmaceutical and biotech companies efficiently navigate drug safety processes. With nearly 100 safety experts worldwide, Insife provides the largest Europe-based pharmacovigilance services and solutions in the industry. The company's flagship product HALOPV is an end-to-end system to manage multivigilance processes from operational to scientific tasks. Insife also offers regulatory intelligence, hosting services, and strategic consulting to deliver outstanding domain expertise across the US, Europe, and Asia. With a commitment to transforming drug safety through innovation, Insife is changing the technology landscape for pharmacovigilance worldwide.
In March 2024, it was announced that Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, had acquired Insife. The acquisition will enable Qinecsa to leverage Insife's expertise in software development and consultancy, to enhance its existing pharmacovigilance services and accelerate further innovation in the field. Together, the companies will continue to lead the industry in advancing patient safety, drug development, and regulatory compliance through AI-driven technologies and cutting-edge solutions.
Exclusive Member Perk
Products
![](https://upload-prod-eu-west-1-insightguide.s3.eu-west-1.amazonaws.com/2f4139b6-18d6-4f46-873c-160777fa6ab1/c01fa1bc-c69d-4278-a204-3ec9c39b15ca.jpg)
PROHALO is cutting-edge technology for your business, in order to comply with pharmac...
The Global Regulatory Intelligence Club for Pharmacovigilance is a unique offering, c...
Recommendations
Refer-a-Friend
Contacts
Natasa Belakon
Insife
Tina Fumic
Insife
Locations
Gladsaxevej 384A, 2860, Søborg, Gladsaxe, Hovedstaden, DNK
Horvatova ulica 80A, 10020, Zagreb, Grad Zagreb, HRV
101 Hudson St, Jersey City, NJ, 07302, USA
Subbelrather Straße 15A, 50823, Cologne, Ehrenfeld, Nordrhein-Westfalen, DEU
9 High Street, Woburn Sands, Milton Keynes, Buckinghamshire, England, MK17 8RF, GBR
Natasa B.
Added Article Insife
26 days ago